Rennova Health (OTCPK:RNVA +20.9%) announced that it has purchased and taken delivery of equipment to provide rapid testing for ((COVID-19)) at three sites, two of its hospitals in East Tennessee and its rural clinic in Kentucky.
Rennova entered an agreement with Abbott Laboratories to install and provide the ID NOW testing facilities.
ID NOW provides results in 15 minutes utilizing state of the art molecular techniques. This test is approved under U.S. Food and Drug Administration Emergency Use Authorization (EUA) from direct nasal or noso-pharyngeal swabs. Testing is expected to begin in September at all 3 facilities. Patients may come to the facilities at their own wish or with a doctor’s order for the testing and leave with a result.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.